A detailed history of American Portfolios Advisors transactions in Immunic, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 62 shares of IMUX stock, worth $65. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62
Holding current value
$65
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$3.0 - $5.49 $186 - $340
62 New
62 $196,000
Q3 2020

Mar 22, 2023

BUY
$11.74 - $22.0 $5,142 - $9,636
438 Added 706.45%
500 $9.29 Million

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $32.1M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.